Royal Bank of Canada’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $7.5M | Sell |
|
|||||
|
2025
Q2 | $7.62M | Buy |
|
|||||
|
2025
Q1 | $7.2M | Buy |
|
|||||
|
2024
Q4 | $6.68M | Buy |
|
|||||
|
2024
Q3 | $6.15M | Buy |
|
|||||
|
2024
Q2 | $5.69M | Sell |
|
|||||
|
2024
Q1 | $7.46M | Sell |
|
|||||
|
2023
Q4 | $7.36M | Buy |
|
|||||
|
2023
Q3 | $6.58M | Sell |
|
|||||
|
2023
Q2 | $7.67M | Sell |
|
|||||
|
2023
Q1 | $8.03M | Buy |
|
|||||
|
2022
Q4 | $8.06M | Sell |
|
|||||
|
2022
Q3 | $7.77M | Buy |
|
|||||
|
2022
Q2 | $7.88M | Sell |
|
|||||
|
2022
Q1 | $8.73M | Buy |
|
|||||
|
2021
Q4 | $8.47M | Buy |
|
|||||
|
2021
Q3 | $6.97M | Sell |
|
|||||
|
2021
Q2 | $9.38M | Buy |
|
|||||
|
2021
Q1 | $8.76M | Buy |
|
|||||
|
2020
Q4 | $7.18M | Buy |
|
|||||
|
2020
Q3 | $4.7M | Sell |
|
|||||
|
2020
Q2 | $9.33M | Buy |
|
|||||
|
2020
Q1 | $3.53M | Sell |
|
|||||
|
2019
Q4 | $7.69M | Sell |
|
|||||
|
2019
Q3 | $9.45M | Buy |
|
|||||
|
2019
Q2 | $6.55M | Sell |
|
|||||
|
2019
Q1 | $6.9M | Buy |
|
|||||
|
2018
Q4 | $3.97M | Buy |
|
|||||
|
2018
Q3 | $4.22M | Sell |
|
|||||
|
2018
Q2 | $6.78M | Sell |
|
|||||
|
2018
Q1 | $7.76M | Sell |
|
|||||
|
2017
Q4 | $9.43M | Buy |
|
|||||
|
2017
Q3 | $4.29M | Buy |
|
|||||
|
2017
Q2 | $4.1M | Sell |
|
|||||
|
2017
Q1 | $6.3M | Sell |
|
|||||
|
2016
Q4 | $8.46M | Buy |
|
|||||
|
2016
Q3 | $6.01M | Sell |
|
|||||
|
2016
Q2 | $7.35M | Sell |
|
|||||
|
2016
Q1 | $9.39M | Sell |
|
|||||
|
2015
Q4 | $18.8M | Buy |
|
|||||
|
2015
Q3 | $14.2M | Sell |
|
|||||
|
2015
Q2 | $19.7M | Buy |
|
|||||
|
2015
Q1 | $15.7M | Buy |
|
|||||
|
2014
Q4 | $11.2M | Buy |
|
|||||
|
2014
Q3 | $9.58M | Sell |
|
|||||
|
2014
Q2 | $9.77M | Buy |
|
|||||
|
2014
Q1 | $9.16M | Buy |
|
|||||
|
2013
Q4 | $8.27M | Sell |
|
|||||
|
2013
Q3 | $7.53M | Buy |
|
|||||
|
2013
Q2 | $7M | Buy |
|